Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
- PMID: 18324404
- DOI: 10.1007/s00280-008-0715-9
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
Abstract
Aim: To evaluate gastrointestinal motility during 5-fluorouracil (5-FU)-induced intestinal mucositis.
Materials and methods: Wistar rats received 5-FU (150 mg kg(-1), i.p.) or saline. After the 1st, 3rd, 5th, 15th and 30th day, sections of duodenum, jejunum and ileum were removed for assessment of epithelial damage, apoptotic and mitotic indexes, MPO activity and GSH concentration. In order to study gastrointestinal motility, on the 3rd or 15th day after 5-FU treatment, gastric emptying in vivo was measured by scintilographic method, and stomach or duodenal smooth muscle contractions induced by CCh were evaluated in vitro.
Results: On the third day of treatment, 5-FU induced a significant villi shortening, an increase in crypt depth and intestinal MPO activity and a decrease in villus/crypt ratio and GSH concentration. On the first day after 5-FU there was an increase in the apoptosis index and a decrease in the mitosis index in all intestinal segments. After the 15th day of 5-FU treatment, a complete reversion of all these parameters was observed. There was a delay in gastric emptying in vivo and a significant increase in gastric fundus and duodenum smooth muscle contraction, after both the 3rd and 15th day.
Conclusion: 5-FU-induced gastrointestinal dysmotility outlasts intestinal mucositis.
Similar articles
-
Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.Cancer Chemother Pharmacol. 2015 Mar;75(3):559-67. doi: 10.1007/s00280-014-2663-x. Epub 2015 Jan 9. Cancer Chemother Pharmacol. 2015. PMID: 25572363
-
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.Cancer Chemother Pharmacol. 2011 Sep;68(3):713-20. doi: 10.1007/s00280-010-1540-5. Epub 2010 Dec 14. Cancer Chemother Pharmacol. 2011. PMID: 21153821
-
Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.Growth Horm IGF Res. 2005 Feb;15(1):72-82. doi: 10.1016/j.ghir.2004.12.002. Epub 2005 Jan 21. Growth Horm IGF Res. 2005. PMID: 15701575
-
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Cancer Chemother Pharmacol. 2016 Nov;78(5):881-893. doi: 10.1007/s00280-016-3139-y. Epub 2016 Sep 2. Cancer Chemother Pharmacol. 2016. PMID: 27590709 Review.
-
[Thyroid-intestinal motility interactions summary].Minerva Gastroenterol Dietol. 2004 Dec;50(4):305-15. Minerva Gastroenterol Dietol. 2004. PMID: 15788986 Review. Italian.
Cited by
-
Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.BMC Gastroenterol. 2012 Jul 13;12:35. doi: 10.1186/1471-230X-12-35. BMC Gastroenterol. 2012. PMID: 22524518 Free PMC article.
-
Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice.J Inflamm Res. 2022 Apr 21;15:2523-2537. doi: 10.2147/JIR.S361039. eCollection 2022. J Inflamm Res. 2022. PMID: 35479832 Free PMC article.
-
5-Fluorouracil Induces Enteric Neuron Death and Glial Activation During Intestinal Mucositis via a S100B-RAGE-NFκB-Dependent Pathway.Sci Rep. 2019 Jan 24;9(1):665. doi: 10.1038/s41598-018-36878-z. Sci Rep. 2019. PMID: 30679569 Free PMC article.
-
Paraprobiotic Lacticaseibacillus rhamnosus Protects Intestinal Damage in an Experimental Murine Model of Mucositis.Probiotics Antimicrob Proteins. 2023 Apr;15(2):338-350. doi: 10.1007/s12602-021-09842-z. Epub 2021 Sep 15. Probiotics Antimicrob Proteins. 2023. PMID: 34524605
-
Effects of Vitamin D-Deficient Diet on Intestinal Epithelial Integrity and Zonulin Expression in a C57BL/6 Mouse Model.Front Med (Lausanne). 2021 Aug 3;8:649818. doi: 10.3389/fmed.2021.649818. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34414198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous